Orphan Drug Consulting, an Irish company that helps pharmaceutical businesses through the process of launching drugs onto the market, is expanding its operations with the opening of a new Australian office focused on the Asia-Pacific market.
Kelly, a veteran of the pharmaceutical industry, founded Orphan Drug Consulting to fill a gap she had noticed while working at a number of pharma companies over a 15-year period. Today, the Enterprise Ireland-backed company has offices in London, Boston and Dublin, and employs 25 full-time staff. In addition, through the help it gives early-stage drug companies, it has played an indirect role in providing employment to many more people, according to Kelly.
The company has helped firms develop treatments for cystic fibrosis as well as several other drugs for lesser-known illnesses. “Quite a lot of them are paediatric, and a large volume are oncologic as well,” Kelly said.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Herkunft: IrishTimesBiz - 🏆 6. / 77 Weiterlesen »